glp-1 novo nordisk glp 1 pill BREAKING: The FDA has approved the first oral for 3 Beaten-Down Stocks With GLP-1

However, other research suggests that it has no benefit

I think theres a real possibility of having those as a commercial product on the market that people would consume or drink before a meal and it would decrease food intake, Hamaker says

And in 2025, Wegovy also received FDA accelerated approval for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis, underscoring that these medications can impact disease processes well beyond body weight alone

Influencers, everyday people and even some medical professionals online now recommend microdosing as a potential solution

El-Mir, M